SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Gut microbiota-derived extracellular vesicles in Parkinson's disease.

iScience · 2026-08-05

DOI: 10.1016/j.isci.2026.117057PMID: 42602545

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

The gut microbiota contributes to the pathophysiology of Parkinson's disease (PD), but the mechanism is not known. Extracellular vesicles (EVs), membrane-enclosed nanosized particles, contain various biomolecules, cross biological barriers, and reach sterile body compartments. We hypothesized that EVs released by the gut microbiota might influence PD pathophysiology. We isolated gut microbiota-derived EVs from the fecal samples of 20 patients with PD and 19 healthy controls. Patients with PD had higher concentrations of fecal EVs, and the mean particle size of EVs was larger. The 16S ribosomal RNA analysis of gut microbiota and microbiota-derived EVs showed taxonomic differences at both the phylum and genus levels between patients with PD and healthy controls. Proteomic analysis of EVs identified unique protein signatures in patients with PD. These findings suggest that gut microbiota-derived EVs constitute a disease-relevant compartment in PD, with their molecular cargo representing a potential mechanistic link between gut microbiota and PD.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.